BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30419858)

  • 1. Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.
    Chua KLM; Yeo ELL; Shihabudeen WA; Tan SH; Shwe TT; Ong EHW; Lam PYP; Soo KC; Soong YL; Fong KW; Tan TWK; Wee JTS; Chua MLK
    BMC Cancer; 2018 Nov; 18(1):1095. PubMed ID: 30419858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
    Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B
    Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes.
    Ozsahin M; Ozsahin H; Shi Y; Larsson B; Würgler FE; Crompton NE
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):429-40. PubMed ID: 9226332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair foci and late apoptosis/necrosis in peripheral blood lymphocytes of breast cancer patients undergoing radiotherapy.
    Marková E; Somsedíková A; Vasilyev S; Pobijaková M; Lacková A; Lukačko P; Belyaev I
    Int J Radiat Biol; 2015; 91(12):934-45. PubMed ID: 26537244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.
    Chua ML; Tan SH; Kusumawidjaja G; Shwe MT; Cheah SL; Fong KW; Soong YL; Wee JT; Tan TW
    Eur J Cancer; 2016 Nov; 67():119-129. PubMed ID: 27640138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
    Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
    Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity.
    De-Colle C; Yaromina A; Hennenlotter J; Thames H; Mueller AC; Neumann T; Stenzl A; Scharpf M; Fend F; Ricardi U; Baumann M; Zips D; Menegakis A
    Radiother Oncol; 2017 Sep; 124(3):386-394. PubMed ID: 28919005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
    BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma.
    Zhang S; Huang X; Zhou L; Wu G; Lin J; Yang S; Chen J; Lin S
    J BUON; 2018; 23(6):1656-1661. PubMed ID: 30610791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
    Henríquez-Hernández LA; Carmona-Vigo R; Pinar B; Bordón E; Lloret M; Núñez MI; Rodríguez-Gallego C; Lara PC
    Radiat Oncol; 2011 Jun; 6():60. PubMed ID: 21645372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients.
    Pinar B; Henríquez-Hernández LA; Lara PC; Bordon E; Rodriguez-Gallego C; Lloret M; Nuñez MI; De Almodovar MR
    Radiat Oncol; 2010 Sep; 5():85. PubMed ID: 20868468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial.
    Fu S; Li Y; Han Y; Wang H; Chen Y; Yan O; He Q; Ma H; Liu L; Liu F
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):101-113. PubMed ID: 35074433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage focus analysis in blood samples of minipigs reveals acute partial body irradiation.
    Lamkowski A; Forcheron F; Agay D; Ahmed EA; Drouet M; Meineke V; Scherthan H
    PLoS One; 2014; 9(2):e87458. PubMed ID: 24498326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
    Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
    Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.